Rheumatoid arthritis Flashcards

1
Q

Outline type II hypersensitivity and give 2 examples

A

Type 2
- Involves antibodies binding to antigens on surface of a cell.
- can lead to 3 things: cell destruction, inflammation, dysfunction.

Cell destruction
-> antibody binds to cell surface antigen
-> activates NK cells -> cell death via cytotoxicity
-> activates phagocytes -> cell death via phagocytosis

Inflammation
-> antibody binds to cell surface antigen
-> activates the complement system -> FC mediated inflammation

Dysfunction
-> binding of antibody to cell surface antigen prevents normal functioning of the cell

Examples:
Transfusion reaction
Myasthenia gravis
Transplant rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Outline type 1 hypersensitivity and give example

A

Type 1
- “First and Fast”
- involves IgE, mast cell and allergen.

*First phase (within minute)
-> antigen cross-links IgE on mast cell leading to immediate degranulation and release of histamine, tryptase , leukotrienes
*Second phase (hours)
-> mast cell releases chemokines + other inflammatory mediators which attract eosinphils
-> leads to further inflammation and tissue damage.

Example: anaphylaxis/ allergic asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Outline type III hypersensitivity and give examples

A

Type III
- Involved immune complexes composed of 3 things: Antibody-antigen-complement.
-antibody is usually IgG

The complex attracts neutrophils which release lysosomal enzymes and can damage tissue.

Examples
Rheumatoid arthritis
Reactive arthritis
Systemic lupus erythematosus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Outline the main steps in the pathophysiology of RA

A
  1. Citrullinated proteins associated with synovial joints, seen as autoantigens, are presented to T cells by antigen presenting cells
  2. T cells are activated, proliferate and release IL-4.
  3. IL-4 activates B cells which change to plasma cells and produce 2 main autoantibodies:
    -> Anti-cyclic-citrullinated peptide (aCCP)
    -> Rheumatoid factor IgM autoantibody.
  4. T cells migrate to synovial joint and release: TNF-a, IL-6, IL-8.
  5. Attracts inflammatory cells, mainly neutrophils and macrophages.
  6. Immune complexes deposit within the joint -> activate inflammatory response via complement system.

Within the joint the following occurs:
(1) reduce hyaluronan
(2) increased matrix metalloproteinases
(3) Synovium hyperplasia
(4) Synovium angiogenesis
–> Non-suppurative inflammatory synovitis.
(5) Granulation tissue + Pannus formation which erodes through cartilage
(6) increased bone resorption through increased RANK-L release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the AA swap to result in citruillination?

A

Arginine -> citrulline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does rheumatoid factor play a role in RA?

What percentage of people with RA are RF+ve ? Name 3 other conditions which can be RF+

A

It is an IgM autoantibody which targets the Fc portion of IgG antibodies and can therefore trigger the complement system/phagocytosis by opsonization.

80% are RF+

Other conditions:
-Sjorgens syndrome
-systemic lupus erythematosus
-endocarditis
-hepatitis B/C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

list 3 tests for RA

what is the specificity of each

A

Serology:
Anti-citrullinated peptide antibodies - 88-98%

Rheumatoid factor 80%

ESR/CRP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does methotrexate results in bone marrow suppression?

A

Methotrexate has anti-folate effects through inhibition of dihydrofolate reductase.

This prevents the formation of purines/pyrimidines which are required by the bone marrow in order to synthesize nucleic acids for new cells.

The cells in bone marrow are rapidly dividing cells, meaning they are susceptible to methotrexate’s effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

outline MOA of methotrexate and list 3 ADR’s

A

Enters cell and becomes polyglutamated
-> antifolate effects: inhibits dihydrofolate reductase
-> anti-inflammatory effects: inhibits AICAR transformylase

This results in increased extracellular adenosine -> activation of A2a receptor leading to the following anti-inflammatory effects:
(1) reduced neutrophil adhesion
(2) reduced macrophage function
(3) reduced cytokine production

ADRS
(1) bone marrow supression -> leucopenia, anemia, thrombocytopenia

(2) GI disturbance: nausea, vomitting, diarrhea

(3) Mucosal ulcers

(4) hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the usual treatment regimen for RA with methorexate?

A

ONCE WEEKLY LOW DOSE methotrexate
Daily folic acid, except on day of MT.
Takes 6-12 weeks to work

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List 3 reasons why Folic acid should be supplemented

A

Reduces GI side effects
Reduces mouth ulcer formation
Protective against hepatotoxicity

NOT protective against bone marrow suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the 3 main components of a synovial joint

A

(1) Joint capsule
- outer layer: Dense fibrous connective tissue, connecting both bones, stability.
-inner layer: loose connective tissue, highly vascularised, synovial fluid production.

(2) Articular cartilage
- Hyaline cartilage on both articulating surfaces: Chondrocytes, type II collagen, GAG’s, proteoglycans, intracellular water.
- partly vascularised- nutrients via diffusion from synovial fluid.
- no perichondrial covering

(3) Fluid-filled synovial cavity
- lined by the synovial membrane made up of cuboidal synoviocytes (3 cell layer thick)
-Type A: hyaluronic acid
-Type B: hyaluronic acid + lysosomal enzymes
-Synovial membrane projects inwards as villi to increase surface area.
-It lacks a basement membrane allowing for rapid diffusion between blood and synovial fluid.

Synovial fluid derived from ultrafiltrate of plasma:
-Water
-Hyaluronic acid
-Glycoproteins
-Lubricin for lubrication
-Proteoglycans
-Phagocytic cells
-lacks clotting factors

Functions:
Lubrication
nutritional support
shock absorption
Ingestion of debris

Rheopectic properties means it becomes more viscous with increasing sheering force

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

outline 5 changes in synovial membrane in RA

A

(1) synovial membrane inflammation and hyperplasia -> non suppurative inflammatory synovitis
(2) hypertrophy with Giant cells and villi formation
(3) Pannus formation
(4) Cartilage and bone erosion -> periarticular osteopenia
(5) PMN infiltrate
(6) Subchondral cysts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define the term monoclonal antibody and outline how they are produced

A

A monoclonal antibody are immunoglobulins derived from a single cell lineage, with a defined specificity for a single antigen.

They are produced through a process called somatic-cell hybridisation:
- a mouse is injected with a specific antigen of interest.
- the B cells from the mouse spleen are harvested
-Hybridoma is produced through fusion of B cells with myeloma cells from human.
-monoclonal antibodies are then derived. a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List 4 groups of biological therapies used for RA

A

TNF-alpha inhibitors e.g. Infliximab/Adalimumab

IL-6 receptor antagonists e.g. Tocilizumab

T cell co-stimulation blockers e.g. Abatacept

B-cell depletion e.g. Rituximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

TNF-alpha inhibitors; drug, MOA, another disease theyre used for, normal effects of TNF-a

A

Inflixumab, Adalimumab, Pegol

MOA:
-Binds to TNF-a thereby preventing it from binding to its own endogenous receptors TNFR-1 + TNFR-2
- prevents its stimulation of inflammatory response

Other condition: Crohn’s disease

Normal function of TNF-a
(1) Induces release of pro-inflammatory cytokines IL-1, IL-6.
(2) increases expression of adhesion molecules.
(3) enhances leukocyte migration from blood.

Released by activated macrophages.

16
Q

IL-6 receptor antagonists:
Drug name,
MOA,
normal function of IL6,
Other conditions used for

A

Tocilizumab

MOA:
-Binds to soluble and membrane bound IL-6 receptors (sIL-6R / mIL-6R) thereby preventing IL-6 from binding.

Normal function of IL-6
(1) T cell activation/expansion/survival
(2) Induction of immunoglobulin release
(3) synthesis of acute phase proteins in liver
(4) stimulation of haematopoeisis

Other condition:
Jeuvinile idiopathic arthritis
psoariatic arthritis

17
Q

T cell co-stimulation blockade

Drug name,
MOA,
Other condition

A

Abatacept

MOA:
-binds to the CD80/86 receptors on surface of ANTIGEN PRESENTING CELL
-Therefore stops the CD28 on T cell from binding = no co-stimulation = no T cell activation

Other condition:
Jeuvenile idiopathic arthritis
psoriatic arthritis

18
Q

B cell depletion

Drug name,
MOA,
Other condition

A

Rituximab

MOA:
- binds to the CD20 on immature/mature B cells.
- results in B cell death by 3 main mechanisms:

(i) Antibody-dependant-cellular cytotoxicity by NK cells, T cells, macrophages -> cell lysis

(ii) Complement-dependant-cytotoxicity- binding of antibody recruits complement system which punches holes in cell membrane -> cell lysis

(iii) Apoptosis; binding of antibody initiates apoptosis of B cell.

Other condition:
Chronic lymphocytic leukemia

19
Q

3 ADR’s of biological therapies

A
  1. infection: TB, septicemia, Hep B reactivation
  2. Hypersensitivity reactions
  3. Nausea, vomiting
20
Q

Define pannus

A

A pannus is an abnormal layer of fibrovascular tissue or granulation tissue. In rheumatoid arthritis it includes inflammatory cells, proliferating synovial cells, granulation tissue and fibrous connective tissue.